t(3;7)(q27;q32) fuses BCL6 to a non-coding region at FRA7H near miR-29
DNA breakage at chromosomal fragile sites (CFS) is believed to promote oncogenic chromosome rearrangement. Notable CFS involvement in leukemia-lymphoma (LL) includes deletions affecting WWOX (located within FRA16D), which is also fused with IGH via t(14;16)(q32;q23) in multiple myeloma, and FHIT at 3p14 (FRA3D) in B-cell lymphoma. Both lesions operate as tumor suppressors and, unlike key LL rearrangements, occur widely in solid tumors. Only 19/89 CFS have been cloned and their coordinates pinpointed. 1 Recent mapping data now show that FRA8C, another leading candidate CFS in LL, lies outside the MYC breakpoint cluster at 8q24. 2 Hence, there remain tantalizingly few leukemic oncogene chromosome rearrangements definitively mapped within CFS. We describe t(3;7) (q27;q32) in a B-cell lymphoma cell line, which fuses BCL6 to a conserved non-coding region within FRA7H, to serve as a unique model for neoplastic fragile site involvement in LL.
The RC-K8 cell line was established from a 55-year-old man with terminal diffuse large B-cell lymphoma (DLBCL) diagnosed originally as 'true histiocytic lymphoma' (www.dsmz.de). Gbanding and chromosome painting revealed the following karyotype: 47, XY, der(Y)t(Y;5)(qter;?p15), der(?1)t(1;13)(p32;q11) del(1)(q11), del(2)(p11p13), dup(2)(p11-12p14-15), t(3;7) (q27;q32), der(5)inv(5)(q15q32)add(5)(q32), inv(5)(p?13q?32), der(8)(t(8;8)(p12;q11), del(9)(p24)x2, der(10)t(9;10)(?p24;p11), À13, t(11;14)(q23;q32), der(14)t(X;14)(p11;p11), À15, der(15) (t(X;15)(p11.3;p11), add(17)(p11), der(20)t(13;20)(q11;q13), þ 2mar. The t(3;7), shown in Figure 1a , is clearly visible in the early passage originators' karyotype where it was then interpreted as t(3;4) indicating stability.
Fluorescence in situ hybridization (FISH) using bacterial artificial chromosome (BAC) and fosmid clones showed that the break at 3q27 lay within BAC RP11-211G11 and fosmid WI2802L21, which both cover the BCL6 major breakpoint Figure 1 Cytogenetic analysis of RC-K8 cells. (a) Partial G-banding analysis of t(3;7)(q27;q32) in RC-K8 cells. (b, c) FISH analysis of BCL6 and FRA7H using tilepath BAC and fosmid clones as summarized in d where BCL6 and FRA7H breakpoints are indicated with arrows. (e) Cell treated with aphidicolin (0.4 mM) for 17 h. Note induction of chromatid breakage within FRA7H clone (arrow) and probably at 3p14/FRA3D (arrow). Clastogenesis favored normal chromosomes, occurring in 17/500 cells (3.4%) compared to 4/500 cells (0.8%) in der(3)/der(7), implying stabilization therein by the formation of t(3;7). (3) showing genes flanking the breakpoint (rectangles). ESTs tested for fusion with BCL6 by RT-PCR (arrows), BCL6 and FLJ43663 fusion for der(3) above der(7), breakpoints (arrows) and deletions of 365 bp on chromosome 3 and 416 bp on chromosome 7 in der(7) are shown (broken gray lines).
Letters to the Editor region (MBR) (Figure 1b) . FISH analysis placed the break at 7q32 within fosmid clone WI2452B9 (Figure 1c ) amid the common fragile site FRA7H (Figure 1d ) first characterized by Mishmar et al. 3 . Aphidicolin clastogenicity assays confirmed that RC-K8 cells are prone to breakage within FRA7H (Figure 1e ). Interestingly, breakage at FRA7H favored sites in normal chromosomes against translocation derivates, implying hightened DNA stability in the latter.
Long distance inverse (LDI)-PCR was performed over a 35 kbp region 5 0 of BCL6 exon 3 including the MBR (Figure 2a and b) . Deviant bands were excised and sequenced (Figure 2a ) and the respective junction sequences for der(3) and der(7) partners determined ( Figure 2c ). As shown in Figure 2d , for der(3), the breakpoint on chromosome 3 lies at 188 947 436 bp (March 2006 Assembly) near the start of the promoter region (Figure 2b ), 1267 bp upstream of exon 1, outwith both MBR and alternative breakpoint regions (ABR), located respectively in exon 1 (silent) together with part of intron 1 and 245-285 kbp upstream thereof. Hence, LDI-PCR identified a novel BCL6 breakpoint indistinguishable from the MBR by FISH alone. While t(3;7) leaves the promoter region intact, der(3) including the coding region of BCL6 is thereby divested of an upstream binding site for BLIMP1, a major BCL6 repressor. 4 Sequencing showed no evidence of somatic hypermutation within the BCL6 promoter.
The breakpoint at 7q32 maps to 130 262 603 bp within FRA7H, confirming the FISH assignment. Although several BCL6 partners map to breakpoints at, or adjacent to, hosting CFS (Supplementary Table 1) , none have on cloning been confirmed to lie within CFS until now. The FRA7H breakpoint lies within putative gene transcripts BC039420/3 0 -FLJ43663, expressed in lymph nodes and B -cells, but silent in myeloid and T cells (http://genome.ucsc.edu). The junction sequence of der(7) differs from that of der(3), with breakpoints at 188 947 802 (chromosome 3) and 130 262 185 bp (chromosome 7) due to deletions of 365 and 416 bp, respectively (Figure 2d ). Interestingly, the deletion of chromosome 3 material excises a region highly conserved in mammalian genomes, the breakpoints precisely marking its boundaries, while the breakpoint in chromosome 7 lies within an Alu element.
Shotgun reverse transcription (RT)-PCR analysis performed to detect formation of hybrid mRNA between BCL6 and compatible (minus-strand) mRNA species at 7q32 provided no evidence of chimeric transcription (Table 1, Figure 2d ). These findings were supported by the results of 5 0 -RACE experiments (data not shown). Thus, t(3;7) in RC-K8 cells is probably nonfusogenic, consistent with placement of the BCL6 breakpoint outside the MBR.
Expression of BCL6, measured by real-time quantitative (RQ)-PCR, showed mid-range BCL6 upregulation in RC-K8 cells when compared with other DLBCL cell lines (Figure 3a) . Western blot analysis confirmed these findings at the protein level (data not shown). Hence, BCL6 is constitutively, albeit moderately, expressedFas previously reported for comparable non-IGH BCL6 rearrangements. 5 To confirm BCL6 signalling, transcriptional profiling was performed on a panel of lymphoma cell lines including RC-K8 (Figure 3b and Supplementary Figure  S1 ). These data show downregulation of major BCL6 program genes, including CITED2, CCND2, ISGF3G, EBI2 and PRDM1, in RC-K8 and other BCL6-rearranged cell lines.
Compared to CFS such as FRA3D and FRA16C, which both exceed 1 Mbp, FRA7H is short (B161 kbp) lessening the risk of adventitious breakage and bolstering its significance in t(3;7). The 7q32 breakpoint adjoined a mammalian interspersed repeat as implicated in leukemic breakpoints, notably the 8.34 kb MLL breakpoint cluster region, which hosts eight Alu copies. 6 To investigate the possible role of DNA sequence instability, stressinduced DNA duplex destabilization (SIDD) analysis of 30 kb surrounding 3q27 and 7q32 breakpoints was performed.
7 SIDD data plotted in Supplementary Figure S2 discount clastogenic destabilization, excepting at the der(7) breakpoint on chromo- Table 1 Oligonucleotides used for RT-PCR analysis of genes/ESTs CTTAATCGTCTCCGGAGTCG  AGGATGCAGAATCCCTCAGGG  194  FLJ43663  XM_379520  ATGAGGCTCAAGCTGACCAG  TTCCCATCCCAAAGTCCTGC  393  FLJ43663  AK125651  ATGATTCTCAAGCTGACCAG  GAGTTCAGTCAGATCGCTGG  379  CCTCACTTCCTGACACAAAC  GACCTGCCAATTTACCAGAG  CTCCTGGGTTCAAGTGATTC  AGAGTTACTCGAACCTCAGG  GAGATACACCTGCTCTCAAC  FLJ43663  BC039420  TGGAATCAGCAACTCCCTGG  GAGCAGACGTTAACACCGAG  338  CAGACAGTGTCTCTTCAACC  FLJ43663  AL049991  CTACTCCATAGGCAGAGCAG  FLJ43663  AL512728  TTTGCTAGTTTGAGGCCACC  FLJ43663  AK122774  AATGCTCTGTCTTGGAAGGG  FLJ43663  BX640882  ATTCCTGGTTCACTCTCAGG  FLJ43663  G30784  CCTCTTCCAAGATGGTGTAC  FLJ43663  BC046223  GATCACCTGCCCACATTTAG  FLJ43663  AL713664  CTGATCTGAGCTCAGACCTG  AK129699  AK129699  CTATAGCCTATACGCCACAC  THC1242508  THC1242508  ACTCCACTGGGCATAATCAG  THC1859096  THC1859096  TTTCACCCTATTGGTCAGGC  FLJ38230  AK095549  TGGTGCTACTTCTACTCCTC  GCTATGTGCTTCACATGGAC  347  CTTCTGCAGTGAATCACTTCC  AGTCTGTCACCTTTGCTTGG  hsa-mir-29a  AJ421751  CTAGCACCATCTGAAATCGG  CCACATGCAATTCAGGTCAG  191  hsa-mir-29b-1  AF480542  AGGAAGCTGGTTTCATATGG  TACATGTGAGGCAGGTTCTC  181 Letters to the Editor some 3, which crests a minor breakage peak (Supplementary Figure S2A ), inviting comparison with another non-coding BCL6 partner breakpoint, which crests a major SIDD peak (Schneider et al., manuscript in preparation). DNA palindromes are implicated in chromosome translocations, including those with CFS involvement. Palindrome analysis of t(3;7) breakpoint regions (http://www.alagu-molbio.net/palin.html) proved negative, however, as did a search for RAG1/2 recombination signal sequences. Canonical MBR rearrangements deregulate BCL6 by promoter exchange. Both ABR and non-clustered breakpoints observed in several DLBCL-derived cell lines (Schneider et al., in preparation.) may effect juxtaposition of BCL6 with cryptic enhancers. Dysregulation by t(3;7) might follow the removal of the upstream binding site for the BCL6 inhibitory regulator BLIMP1 (Figure 2b ) or juxtaposition with a 38 bp tract of abyssally cross-species conserved non-coding DNA at chromosome 7 (130 262 603-130 262 640 bp). This sequence forms a '7X Regulatory Region' (mean value ¼ 0.12; http:// genome.ucsc.edu/cgi)), warranting its further evaluation. Analogous non-coding regions located B1 Mbp downstream of their coordinate target gene, BCL11B, mediate ectopic gene deregulation in T-cell leukemia. 8 Although FRA7H lacks RefSeq genes, it bears a micro-RNA gene cluster, located B50 kbp centromeric of the breakpoint. One of its two transcripts, miR-29b-1, is downregulated in RC-K8 compared to other DLBCL cell lines lacking 7q32 involvement (Figure 3c ) while miR-29a is expressed throughout. Interestingly, miR-29b-1, which regulates target expression in B cells, has recently been highlighted as a target of 7q32 deletions in splenic marginal zone lymphoma. 9 Mir genes have attracted attention of late by their placement close to either LL translocation breakpoints or to CFS.
10 Uniquely, the miR-29 cluster near the 7q32 breakpoint in RC-K8 cells displays both attributes.
The contribution of CFS to cancer remains poorly understood. The RC-K8 cell line in which BCL6 is fused to a non-coding region within FRA7H thus serves as a unique paradigm and tool for investigating CFS involvement in leukemogenic chromosome rearrangement. T-cell acute lymphoblastic leukemia (T-ALL) is a malignant disease of progenitor T cells that have undergone multiple genetic alterations. Translocations between T-cell receptor (TCR) genes and genes with oncogenic properties are a genetic hallmark of this disease. Most of these oncogenes encode transcription factors, the deregulated expression of which causes a block in the development of progenitor T cells. Until recently, most of these TCR chromosomal rearrangements were attributed to erroneous recombinations involving the a/d (TCRA/D) locus. However, new approaches uncovering cryptic chromosomal rearrangements revealed a higher incidence of TCRB locus-associated aberrations leading to the identification of new oncogenes involved in T-ALL leukemogenesis.
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Here, we present a novel chromosomal aberration involving the TCRB locus and the 10p12 region in a previously described TCRgd þ T-ALL (T003/MA). 3 Cytogenetic analysis on bone marrow material of T003, a 7-year-old male patient, revealed a complex karyotype: 46, XY,add(5)(q13),der(7)?inv(7)(p1?q3?),add(10)(q21),del(10)(q25) [26]/45,idem,-Y [4] ,46,XY [6] . Chromosomal rearrangements involving the q arm of chromosome 7 usually suggest the involvement of TCRB genes in T-ALL cases. Southern blot analysis of the TCRB gene revealed the presence of a 5.35 kb band representing a Db1-Jb2 rearrangement on one allele, while the second allele contained an atypical TCRB gene rearrangement of 4.4 kb within the b2 region (Figure 1 ). 4 In order to resolve the nature of this unknown TCRB gene rearrangement, we performed a ligation-mediated PCR, as previously described, 5 using Db2-specific nested primers. Sequencing revealed the presence of a fusion of the 3 0 end of the Db2 gene segment and the p12 region of chromosome 10, representing the derivative chromosome der(7) (Figure 2a) . Furthermore, a second ligation-mediated PCR analysis performed with nested primer sets directed to the Jb2.2, Jb2.5 and Jb2.7 regions revealed the reciprocal der(10) containing a fusion between the centromeric side of 10p12 and the 5 0 side of the Jb2.3 gene segment (Figure 2a) . Additionally, our data showed that the break on chromosome 10 occurred in the absence of cryptic recombination signal sequences, indicative of a 'type 2' translocation. 6 The breakpoint was localized between the p11 and p12 bands on chromosome 10, proximal to the centromere (reference sequence: NT_008705.15) (Figure 2b ). This area encompasses the genes DNAJC1 and AF10/MLLT10, which are located B35 and B504 kb telomeric to the break, respectively, and COMMD3 and BMI1, which are located B277 and B282 kb centromeric to the break, respectively (Figure 2b ).
Our data suggest that the der(7) resulted from a possible translocation with the distal part of chromosome 10p, thereby Figure 1 Southern blot analysis of TCRB gene rearrangement in T003. Control and T003 DNA were digested with EcoRI preceded by blotting and hybridization with a 32 P-labeled TCRbJ2 probe. As expected, in the control sample, a germline (G) fragment of 4.1 kb was detected while T003 showed a Db1-Jb2 rearrangement of 5.35 kb and an atypical rearrangement (R?) of 4.4 kb.
